EFEMP1 and central nervous system cancer: It is worth highlighting that some of the strongest evidence implicating fibulin-3 causally in tumour progression has arisen in the context of glioma, conceptually consistent with the implication of EFEMP1 in a genetic susceptibility to glioma via GWAS.